helmholtzeyeinstituteРоссийский офтальмологический журналRussian Ophthalmological Journal2072-00762587-5760Real time Publishers10.21516/2072-0076-2024-17-2-99-107helmholtzeyeinstitute-1497Research ArticleВ ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУFOR OPHTHALMOLOGY PRACTITIONERSПути повышения эффективности фильтрующей хирургии глаукомыWays to improve the effectiveness of glaucoma filtering surgeryhttps://orcid.org/0000-0002-6393-1289НиколаенкоВ. П.NikolaenkoV. P.

Вадим Петрович Николаенко — д-р мед. наук, профессор кафедры оториноларингологии и офтальмологии; заместитель главного врача по офтальмологии 

Университетская наб., д. 7/9, Санкт-Петербург, 199106;Учебный переулок, д. 5, Санкт-Петербург, 194354

Vadim P. Nikolaenko — Dr. of Med. Sci., professor, department of otorhinolaryngology and ophthalmology; deputy chief physician for ophthalmology 

7/9, Universitetskaya Emb., St. Petersburg, 199106;5, Uchebny Lane, St. Petersburg, 194354

https://orcid.org/0000-0002-2639-2765АнтоноваА. В.AntonovaA. V.

Анастасия Валерьевна Антонова — ассистент кафедры оториноларингологии и офтальмологии1, врач-офтальмолог 

Университетская наб., д. 7/9, Санкт-Петербург, 199106;Учебный переулок, д. 5, Санкт-Петербург, 194354

Anastasiya V. Antonova — assistant of chair of otorhinolaryngology and ophthalmology; ophthalmologist 

7/9, Universitetskaya Emb., St. Petersburg, 199106;5, Uchebny Lane, St. Petersburg, 194354

dr.antonova.av@gmail.comhttps://orcid.org/0000-0001-7361-0270БржескийВ. В.BrzheskyV. V.

Владимир Всеволодович Бржеский — д-р мед. наук, профессор, заведующий кафедрой офтальмологии 

ул. Литовская, д. 2, Санкт-Петербург, 194100

Vladimir V. Brzhesky — Dr. of Med. Sci., head of chair of ophthalmology  

2, Litovskaya St., St. Petersburg, 194100

ФГБОУ ВО «Санкт-Петербургский государственный университет»; СПб ГБУЗ «Городская многопрофильная больница № 2»РоссияSt. Petersburg State University; City Multidisciplinary Hospital No. 2Russian FederationФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава РоссииРоссияSt. Petersburg State Pediatric Medical UniversityRussian Federation20240107202417299107Copyright © Николаенко В.П., Антонова А.В., Бржеский В.В., 20242024Николаенко В.П., Антонова А.В., Бржеский В.В.Nikolaenko V.P., Antonova A.V., Brzhesky V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://roj.igb.ru/jour/article/view/1497

В статье представлены различные способы повышения эффективности антиглаукомных операций фильтрующего типа. Особое внимание уделяется сохранению здоровой глазной поверхности с помощью назначения оптимальной терапии глаукомы. Длительность заболевания следует обязательно учитывать при выборе гипотензивного вмешательства и построении алгоритма его фармакологического сопровождения, состоящего из предоперационной подготовки, пролонгированного послеоперационного противовоспалительного лечения и кератопротекции.

The article presents a variety of ways to increase the efficiency of glaucoma filtering surgery. Special attention is given to maintaining the ocular surface healthy through optimal glaucoma therapy. The duration of the disease should be taken into account when choosing the type of hypotensive surgery and designing an algorithm for its pharmacological support: preoperative preparation, prolonged postoperative anti-inflammatory treatment and cornea protection.

глаукомасинустрабекулэктомияхирургия глаукомыглазная поверхностьпротивовоспалительное лечениеglaucomatrabeculectomyglaucoma surgeryocular surfaceanti-inflammatory treatmentReferencesEuropean Glaucoma Society Terminology and Guidelines for Glaucoma, 5; Savona. PubliComm; 2020.European Glaucoma Society Terminology and Guidelines for Glaucoma, 5; Savona. PubliComm; 2020.Глаукома первичная открытоугольная. Клинические рекомендации. Москва; 2020.Primary open angle glaucoma. Clinical Guidelines. Moscow; 2020 (In Russ.).Gedde SJ, Vinod K, Wright MM, et al. American Academy of Ophthalmology preferred practice pattern glaucoma panel. Primary open-angle glaucoma preferred practice pattern. Jan 2020; 128 (1): 71–150. doi: 10.1016/j.ophtha.2020.10.022Gedde SJ, Vinod K, Wright MM, et al. American Academy of Ophthalmology preferred practice pattern glaucoma panel. Primary open-angle glaucoma preferred practice pattern. Jan 2020; 128 (1): 71–150. doi: 10.1016/j.ophtha.2020.10.022Tanna AP. Basic and clinical science course. Section 10. Glaucoma. American Academy of Ophthalmology. San Francisco: AAO, 2022–2023.Tanna AP. Basic and clinical science course. Section 10. Glaucoma. American Academy of Ophthalmology. San Francisco: AAO, 2022–2023.Weinreb RN, Ramulu P, Topouzis F, et al. 11th Consensus Meeting: Glaucoma Surgery. World Glaucoma Association, 2019.Weinreb RN, Ramulu P, Topouzis F, et al. 11th Consensus Meeting: Glaucoma Surgery. World Glaucoma Association, 2019.Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999; 106 (3): 556–63. doi: 10.1016/S0161-6420(99)90116-1Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999; 106 (3): 556–63. doi: 10.1016/S0161-6420(99)90116-1Thorne JE, Anhalt GJ, Jabs DA. Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology. 2004; 111 (1): 45–52. doi: 10.1016/j.ophtha.2003.03.001Thorne JE, Anhalt GJ, Jabs DA. Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology. 2004; 111 (1): 45–52. doi: 10.1016/j.ophtha.2003.03.001Asbell PA, Potapova N. Effects of topical antiglaucoma medications on the ocular surface. Ocular Surface. 2005; 3 (1): 27–40. doi: 10.1016/s1542-0124(12)70120-9Asbell PA, Potapova N. Effects of topical antiglaucoma medications on the ocular surface. Ocular Surface. 2005; 3 (1): 27–40. doi: 10.1016/s1542-0124(12)70120-9Hong S, Lee CS, Seo KY, Seong GJ, Hong Y J. Effects of topical antiglaucoma application on conjunctival impression cytology specimens. Am J Ophthalmol. 2006 Jul; 142 (1): 185–6. doi: 10.1016/j.ajo.2006.02.056Hong S, Lee CS, Seo KY, Seong GJ, Hong Y J. Effects of topical antiglaucoma application on conjunctival impression cytology specimens. Am J Ophthalmol. 2006 Jul; 142 (1): 185–6. doi: 10.1016/j.ajo.2006.02.056Servat JJ, Bernardino CR. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Drugs Aging. 2011 Apr 1; 28 (4): 267–82. doi: 10.2165/11588830-000000000-00000Servat JJ, Bernardino CR. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Drugs Aging. 2011 Apr 1; 28 (4): 267–82. doi: 10.2165/11588830-000000000-00000Lavin MJ, Wormald RP, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol. 1990; 108 (11): 1543–8. doi: 10.1001/archopht. 1990.01070130045027Lavin MJ, Wormald RP, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol. 1990; 108 (11): 1543–8. doi: 10.1001/archopht. 1990.01070130045027Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication II. The outcome of filtration surgery. Arch Ophthalmol. 1994; 112 (11): 1446–54. doi: 10.1001/archopht.1994.01090230060021Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication II. The outcome of filtration surgery. Arch Ophthalmol. 1994; 112 (11): 1446–54. doi: 10.1001/archopht.1994.01090230060021Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication I. The conjunctival cell profile. Arch Ophthalmol. 1994; 112 (11): 1437–45. doi: 10.1001/archopht.1994.01090230051020Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication I. The conjunctival cell profile. Arch Ophthalmol. 1994; 112 (11): 1437–45. doi: 10.1001/archopht.1994.01090230051020Helin M, Rönkkö S, Puustjärvi T, et al. Conjunctival inflammatory cells and their predictive role for deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma. J Glaucoma. 2011; 20 (3): 172–8. doi: 10.1097/IJG.0b013e3181d9ccb0Helin M, Rönkkö S, Puustjärvi T, et al. Conjunctival inflammatory cells and their predictive role for deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma. J Glaucoma. 2011; 20 (3): 172–8. doi: 10.1097/IJG.0b013e3181d9ccb0Boimer C, Birt CM. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study. J Glaucoma. 2013; 22 (9): 730–5. doi: 10.1097/IJG.0b013e31825af67dBoimer C, Birt CM. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study. J Glaucoma. 2013; 22 (9): 730–5. doi: 10.1097/IJG.0b013e31825af67dHelin-Toiviainen M, Rönkkö S, Puustjärvi T, et al. Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients. Acta ophthalmologica. 2015 Mar; 93 (2): 165–71. doi: 10.1111/aos.12550Helin-Toiviainen M, Rönkkö S, Puustjärvi T, et al. Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients. Acta ophthalmologica. 2015 Mar; 93 (2): 165–71. doi: 10.1111/aos.12550Aritüгk N, Oge I, Baris S, et al. The effects of antiglaucomatous agents on conjunctiva used for various durations. Int. Ophthalmol. 1996–1997; 20 (1–3): 57–62. doi: 10.1007/BF00212947Aritüгk N, Oge I, Baris S, et al. The effects of antiglaucomatous agents on conjunctiva used for various durations. Int. Ophthalmol. 1996–1997; 20 (1–3): 57–62. doi: 10.1007/BF00212947Антонова А.В., Николаенко В.П., Бржеский В.В., Вукс А.Я. Факторы, снижающие эффективность синустрабекулэктомии: по материалам Санкт-Петербургского городского офтальмологического центра. Офтальмологические ведомости. 2022; 15 (4): 35–44. doi: 10.17816/OV159363Antonova A.V., Nikolaenko V.P., Brzheskiy V.V., Vuks A.Ja. Factors influencing the effectiveness of trabeculectomy: following materials of the City Multidisciplinary Hospital No. 2. Ophthalmology Reports. 2022; 15 (4): 35–44 (In Russ.). doi: 10.17816/OV159363Agnifili L, Mastropasqua R, Fasanella V, et al. Gland features and conjunctival goblet cell density in glaucomatous patients controlled with prostaglandin/timolol fixed combinations: A case control, cross-sectional study. J Glaucoma. 2018; 27 (4): 364–70. doi: 10.1097/IJG. 0000000000000899Agnifili L, Mastropasqua R, Fasanella V, et al. Gland features and conjunctival goblet cell density in glaucomatous patients controlled with prostaglandin/timolol fixed combinations: A case control, cross-sectional study. J Glaucoma. 2018; 27 (4): 364–70. doi: 10.1097/IJG. 0000000000000899Mastropasqua L, Agnifili L, Fasanella V, et al. Conjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology study. Acta Ophthalmol. 2013; 91 (5): e397-405. doi: 10.1111/aos.12131Mastropasqua L, Agnifili L, Fasanella V, et al. Conjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology study. Acta Ophthalmol. 2013; 91 (5): e397-405. doi: 10.1111/aos.12131Russ HH, Costa VP, Ferreira FM, et al. Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study. Arq Bras Oftalmol. 2007; 70 (6): 910–6. doi: 10.1590/s0004-27492007000600005Russ HH, Costa VP, Ferreira FM, et al. Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study. Arq Bras Oftalmol. 2007; 70 (6): 910–6. doi: 10.1590/s0004-27492007000600005Rodríguez Uña I, Martínez-de-la-Casa JM, Pablo Júlvez L, et al. Perioperative pharmacological management in patients with glaucoma. Arch Soc Esp Oftalmol. 2015; 90 (6): 274–84. doi: 10.1016/j.oftal.2014.06.003Rodríguez Uña I, Martínez-de-la-Casa JM, Pablo Júlvez L, et al. Perioperative pharmacological management in patients with glaucoma. Arch Soc Esp Oftalmol. 2015; 90 (6): 274–84. doi: 10.1016/j.oftal.2014.06.003Guenoun JM, Baudouin C, Rat P, et al. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005; 46 (7): 2444–50. doi: 10.1167/iovs.04-1331Guenoun JM, Baudouin C, Rat P, et al. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005; 46 (7): 2444–50. doi: 10.1167/iovs.04-1331Kim EJ, Kim YH, Kang SH, Lee KW, Park YJ. In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells. Korean J Ophthalmol. 2013; 27 (6): 446–53. doi: 10.3341/kjo.2013.27.6.446Kim EJ, Kim YH, Kang SH, Lee KW, Park YJ. In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells. Korean J Ophthalmol. 2013; 27 (6): 446–53. doi: 10.3341/kjo.2013.27.6.446Обловацкая Е.С., Николаенко В.П. Место дренажа Ахмеда в хирургии глаукомы. Национальный журнал Глаукома. 2022; 21 (2): 35–41. doi: 10.53432/2078-4104-2022-21-2-35-41Oblovatskaya E.S., Nikolaenko V.P. Ahmed valve implant and its place in the surgical treatment of glaucoma. National journal glaucoma. 2022; 21 (2): 35–41 (In Russ.). doi: 10.53432/2078-4104-2022-21-2-35-41Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001; 108 (11): 1943–53. doi: 10.1016/s0161-6420(01)00873-9Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001; 108 (11): 1943–53. doi: 10.1016/s0161-6420(01)00873-9Richter CU, Shingleton, BJ, Bellows AR, et al. The development encapsulated filtering blebs. Ophthalmology. 1988 Sep; 95 (9): 1163–8. doi: 10.1016/s0161-6420(88)33041-1Richter CU, Shingleton, BJ, Bellows AR, et al. The development encapsulated filtering blebs. Ophthalmology. 1988 Sep; 95 (9): 1163–8. doi: 10.1016/s0161-6420(88)33041-1Garcia-Feijoo J, Sampaolesi JR. A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma. Clin Ophthalmol. 2012; 6: 441–6. doi: 10.2147/OPTH. S29158Garcia-Feijoo J, Sampaolesi JR. A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma. Clin Ophthalmol. 2012; 6: 441–6. doi: 10.2147/OPTH. S29158Антонова А.В., Николаенко В.П., Бржеский В.В., Вукс А.Я. Эффективность синустрабекулэктомии в современной клинической практике. Клиническая офтальмология. 2023; 23 (1): 21–6. doi: 10.32364/2311-7729-2023-23-1-21-26Antonova A.V., Nikolaenko V.P., Brzhesky V.V., Vuks A.Ya. The efficacy of sinustrabeculectomy in the modern clinical practice. Clinical Ophthalmology. 2023; 23 (1): 21–6 (in Russ.). doi: 10.32364/2311-7729-2023-23-1-21-26Shaarawy T, Sherwood MB., Crowston JG. Glaucoma: Medical diagnosis & therapy. Elsevier Health Sciences, 2009.Shaarawy T, Sherwood MB., Crowston JG. Glaucoma: Medical diagnosis & therapy. Elsevier Health Sciences, 2009.Tailor R, Batra R, Mohamed S. A national survey of glaucoma specialists on the preoperative (trabeculectomy) management of the ocular surface. Semin. Ophthalmol. 2016; 31 (6): 519–25. doi: 10.3109/08820538.2014.986585Tailor R, Batra R, Mohamed S. A national survey of glaucoma specialists on the preoperative (trabeculectomy) management of the ocular surface. Semin. Ophthalmol. 2016; 31 (6): 519–25. doi: 10.3109/08820538.2014.986585Chamard C, Larrieu S, Baudouin C, et al. Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008–2016. Acta Ophthalmol. 2020; 98 (7):e876-e881. doi: 10.1111/aos.14410Chamard C, Larrieu S, Baudouin C, et al. Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008–2016. Acta Ophthalmol. 2020; 98 (7):e876-e881. doi: 10.1111/aos.14410Сафонова Т.Н., Федоров А.А., Забегайло А.О., Егорова Г.Б., Митичкина Т.С. Лечение синдрома сухого глаза при первичной глаукоме. Национальный журнал Глаукома. 2015; 14 (4): 36–43.Safonova T.N., Fedorov A.A., Zabegaylo A.O., Egorova G.B., Mitichkina T.S. Treatment of dry eye syndrome by primary glaucoma. National journal Glaucoma. 2015; 14 (4): 36–43 (In Russ.).Егорова Г.Б., Аверич В.В. Снижение цитотоксического действия консерванта в составе офтальмогипотензивных препаратов с помощью слезозаместительной терапии. Вестник офтальмологии. 2018; 134 (3): 48–56. doi: 10.17116/oftalma 2018134348Egorova G.B., Averich V.V. Reducing cytotoxic action of the preservative employed in ophthalmic hypotensive medications with tear replacement therapy. Vestnik oftal’mologii. 2018; 134 (3): 48–56 (In Russ.). doi: 10.17116/oftalma 2018134348Макашова Н.В., Васильева А.Е., Колосова О.Ю. Влияние слезозаменителей на состояние поверхности глаза при длительном использовании гипотензивных средств с консервантами. Вестник офтальмологии. 2018; 134 (2): 59–65. doi 10.17116/oftalma2018134259-65Makashova N.V., Vasil'eva A.E., Kolosova O.Yu. Effects of artificial tears on ocular surface in glaucomatous patients with long-term instillation of preserved antiglaucoma eye drops. Vestnik oftal’mologii. 2018; 134 (2): 59–65 (In Russ.). doi 10.17116/oftalma2018134259-65Nguyen KD, Lee DA. Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast. Invest Ophthalmol Vis Sci. 1992 Aug; 33 (9): 2693–701. PMID: 1386351.Nguyen KD, Lee DA. Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast. Invest Ophthalmol Vis Sci. 1992 Aug; 33 (9): 2693–701. PMID: 1386351.Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol. 2008; 4 (10): 525–33. https://doi.org/10.1038/ncprheum0898Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol. 2008; 4 (10): 525–33. https://doi.org/10.1038/ncprheum0898Löwenberg M, Stahn C, Hommes DW, Buttgereit F. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids. 2008; 73 (9–10): 1025–9. doi: 10.1016/j.steroids.2007.12.002Löwenberg M, Stahn C, Hommes DW, Buttgereit F. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids. 2008; 73 (9–10): 1025–9. doi: 10.1016/j.steroids.2007.12.002Stewart RH, Smith JP, Rosenthal AL. Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate. Curr Eye Res. 1984; 3 (6): 835–9. doi: 10.3109/02713688409000796Stewart RH, Smith JP, Rosenthal AL. Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate. Curr Eye Res. 1984; 3 (6): 835–9. doi: 10.3109/02713688409000796Петров С.Ю., Антонов А.А., Макарова А.С., Вострухин С.В., Сафонова Д.М. Возможности пролонгации гипотензивного эффекта трабекулэктомии. Вестник офтальмологии. 2015; 131 (1): 75–81. doi: 10.17116/oftalma2015131175-81Petrov S.Yu., Antonov A.A., Makarova А.S., Vostrukhin S.V., Safonova D.М. Options for prolonging the hypotensive effect of trabeculectomy. Vestnik otal’mologii. 2015; 131 (1): 75–81 (in Russ.). doi: 10.17116/oftalma2015131175-81Broadway DC, Grierson I, Stürmer J, Hitchings RA. Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol. 1996; 114 (3): 262–7. doi: 10.1001/archopht.1996.01100130258004Broadway DC, Grierson I, Stürmer J, Hitchings RA. Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol. 1996; 114 (3): 262–7. doi: 10.1001/archopht.1996.01100130258004Mastropasqua L, Brescia L, D’Arcangelo F, et al. Topical steroids and glaucoma filtration surgery outcomes: an in vivo confocal study of the conjunctiva. J Clin Med. 2022; 11 (14): 3959. doi: 10.3390/ jcm11143959Mastropasqua L, Brescia L, D’Arcangelo F, et al. Topical steroids and glaucoma filtration surgery outcomes: an in vivo confocal study of the conjunctiva. J Clin Med. 2022; 11 (14): 3959. doi: 10.3390/ jcm11143959Taniguchi J, Sharma A. Fluorometholone modulates gene expression of ocular surface mucins. Acta Ophthalmol. 2019; 97 (8): e1082-e1088. doi: 10.1111/aos.14113Taniguchi J, Sharma A. Fluorometholone modulates gene expression of ocular surface mucins. Acta Ophthalmol. 2019; 97 (8): e1082-e1088. doi: 10.1111/aos.14113Александрова О.И., Околов И.Н., Хорольская Ю.И., Панова И.Е., Блинова М.И. Влияние нестероидных противовоспалительных глазных капель на клетки эпителия роговицы и конъюнктивы человека в условиях in vitro. Офтальмология. 2017; 15 (3): 251–9. doi: 10.18008/1816-5095-2017-3-251-259Aleksandrova O.I., Okolov I.N., Khorolskaya Yu.I., Panovа I.E., Blinova M.I. Influence of non-steroid antiinflammatory eye drops on the epithelium cells of the cornea and conjunctiva in vitro. Ophthalmology in Russia. 2017; 15 (3): 251–9 (In Russ.). doi: 10.18008/1816-5095-2017-3-251-259Николаенко В.П., Бржеский В.В., Антонова А.В. Расширение показаний к имплантации клапана Ахмеда. Офтальмологические ведомости. 2023; 6 (2) :83–90. doi: 10.17816/OV340821Nikolaenko V.P., Brzheskiy V.V., Antonova А.V. The extension of indications for the implantation of Ahmed valve. Ophthalmology reports. 2023; 16 (2): 83–90 (In Russ.). doi: 10.17816/OV340821Pérez-Bartolomé F, Martínez-de-la-Casa JM, Arriola-Villalobos P, et al. Ocular surface disease in patients under topical treatment for glaucoma. Eur J Ophthalmol. 2017; 27 (6): 694–704. doi: 10.5301/ejo.5000977Pérez-Bartolomé F, Martínez-de-la-Casa JM, Arriola-Villalobos P, et al. Ocular surface disease in patients under topical treatment for glaucoma. Eur J Ophthalmol. 2017; 27 (6): 694–704. doi: 10.5301/ejo.5000977Антонова А.В., Николаенко В.П., Бржеский В.В. Реализация каскадного алгоритма лечения глаукомы в Санкт-Петербурге. РМЖ. Клиническая офтальмология. 2021; 3: 123–8. doi: 10.32364/2311-7729-2021-21-3-123-128Antonova A.V., Nikolaenko V.P., Brzheskiy V.V. Realization of a cascade treatment algorithm for glaucoma in St. Petersburg. Russian journal of clinical ophthalmology. 2021; 21 (3): 123–8 (In Russ.). doi: 10.32364/2311-7729-2021-21-3-123-128Антонова А.В., Николаенко В.П., Бржеский В.В., Вукс А.Я., Коскин С.А. Влияние некоторых общих заболеваний на изменения глазной поверхности после синустрабекулэктомии. Офтальмологические ведомости. 2024; 17 (1): 7–19. doi:10.17816/OV568993Antonova A.V., Nikolaenko V.P., Brzeskii V.V., Vuks A.Ja., Koskin S.A. The influence of some general diseases for changes on the ocular surface after trabeculectomy. Ophthalmology reports. 2024; 17 (1): 7–19 (In Russ.). doi:10.17816/OV568993Husain R, Liang S, Foster PJ, et al. Cataract surgery after trabeculectomy: the effect on trabeculectomy function. Arch Ophthalmol. 2012; 130 (2): 165–70. doi: 10.1001/archophthalmol.2011.329Husain R, Liang S, Foster PJ, et al. Cataract surgery after trabeculectomy: the effect on trabeculectomy function. Arch Ophthalmol. 2012; 130 (2): 165–70. doi: 10.1001/archophthalmol.2011.329Klink J, Schmitz B, Lieb WE, et al. Filtering bleb function after clear cornea phacoemulsification: a prospective study. Br J Ophthalmol. 2005; 89 (5): 597–601. doi: 10.1136/bjo.2004.041988Klink J, Schmitz B, Lieb WE, et al. Filtering bleb function after clear cornea phacoemulsification: a prospective study. Br J Ophthalmol. 2005; 89 (5): 597–601. doi: 10.1136/bjo.2004.041988Ehrnrooth P, Lehto I, Puska P, Laatikainen L. Phacoemulsification in trabeculectomized eyes. Acta Ophthalmol Scand. 2005 Oct; 83 (5): 561–6. doi: 10.1111/j.1600-0420.2005.00499.xEhrnrooth P, Lehto I, Puska P, Laatikainen L. Phacoemulsification in trabeculectomized eyes. Acta Ophthalmol Scand. 2005 Oct; 83 (5): 561–6. doi: 10.1111/j.1600-0420.2005.00499.xCrichton ACS, Kirker AW. Intraocular pressure and medication control after clear corneal phacoemulsification and AcrySof posterior chamber intraocular lens implantation in patients with filtering blebs. J Glaucoma. 2001 Feb; 10 (1): 38–46. doi: 10.1097/00061198-200102000-00008Crichton ACS, Kirker AW. Intraocular pressure and medication control after clear corneal phacoemulsification and AcrySof posterior chamber intraocular lens implantation in patients with filtering blebs. J Glaucoma. 2001 Feb; 10 (1): 38–46. doi: 10.1097/00061198-200102000-00008Halikiopoulos D, Moster MR, Azuara-Blanco A, et al. The outcome of the functioning filter after subsequent cataract extraction. Ophthalmic Surg Lasers. 2001 Mar-Apr; 32 (2): 108–17. PMID: 11300631Halikiopoulos D, Moster MR, Azuara-Blanco A, et al. The outcome of the functioning filter after subsequent cataract extraction. Ophthalmic Surg Lasers. 2001 Mar-Apr; 32 (2): 108–17. PMID: 11300631Aptel F, Colin C, Kaderli S, et al. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol. 2017; 101 (11): 1–10. doi: 10.1136/bjophthalmol-2017-310324Aptel F, Colin C, Kaderli S, et al. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol. 2017; 101 (11): 1–10. doi: 10.1136/bjophthalmol-2017-310324Khaw PT, Bouremel Y, Brocchini S, et al. The control of conjunctival fibrosis as a paradigm for the prevention of ocular fibrosis-related blindness. “Fibrosis has many friends”. Eye (Lond). 2020; 34 (12): 2163–74. doi: 10.1038/s41433-020-1031-9Khaw PT, Bouremel Y, Brocchini S, et al. The control of conjunctival fibrosis as a paradigm for the prevention of ocular fibrosis-related blindness. “Fibrosis has many friends”. Eye (Lond). 2020; 34 (12): 2163–74. doi: 10.1038/s41433-020-1031-9Егоров Е.А., Куроедов А.В., ред. Первичная открытоугольная глаукома. Национальное руководство. Москва: ГЭОТАР-Медиа, 2023.Egorov E.A., Kuroyedov A.V., eds. Primary open-angle glaucoma. National Guidelines. Moscow: GEOTAR-Media, 2023 (In Russ.).

The authors declare that there are no conflicts of interest present.